2Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathal Oral Radiol Endod,1995,79:321-329.
3Kelloff GJ, Sigman CC, Johnson KM, et al. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer. Cancer Epidemiol Biomarkers Prev,2000,9:127-137.
5Chattopadhyay A, Ray JG, Caplan DJ. AgNOR count as objective marker for dysplastic features in oral leukoplakia. J Oral Pathol Med,2002,31: 512-517.
6Schliephake H. Prognostic relevance of molecular markers of oral cancer --a review. Int J Oral Maxillofac Surg,2003,32:233-245.
7Liu SC, Klein-Szanto AJ. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol,2000,36 :145-151.
8Mutirangura A, Supiyaphun P, Trirekapan S, et al. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res,1996,56: 3530-3533.
9Piattelli A, Rubini C, Fioroni M, et al. Prevalence of p53 , bcl-2 and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity. J Oral Maxillofac Surg,2002,60:532-540.
10Lo Muzio L, Pannone G, Leonardi R, et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res,2003,82: 923-928.
二级参考文献9
1. DNA recommendations —1994 report concerning further recommendations of the DNA Commission of the ISM regarding PCR-based polymorphisms in STR (short tandem repeat) systems[J] 1994,International Journal of Legal Medicine(3):159～160
2Tannapeel A,Nublein S,Fietkau R,et al.Apoptosis, proliferation, Bax Bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer[].J Radiol Oncol Biol Phys.1998
3Lebrun DP,Warnke RA.Expression of Bcl-2 in fetal tissues suggests a role in morphogenesis[].American Journal of Pathology.1994
4Olivai Z,Milliman C,Yang T,et al.Bcl-2 heterodimers in vivo with a conserved homologen, Bax, that accelerated programmed cell death[].Cell.1993
5Scott N,Hale A,Deakin M,et al.A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression[].European Journal of Surgical Oncology.1998
6Strasser A,Harris AW,Huang DCS,et al.Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis[].EMBO Journal.1995
8Fisher TC,Milner A,Oltari T,et al.Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways[].Cancer Research.1993
9Apolinario RM,Vallk PV,Jong JS,et al.Prognostic value of the expression of p53, Bcl-2 and Bax oncoproteins, and neovascularization in patients with radically resected non-smallcell lung cancer[].Journal of Clinical Oncology.1998
3Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc,2001,132 Suppl:7S-11S.
4Kramer IR, Lucas RB, Pindborg JJ, et al. Definition of leukoplakia and related lesions: an aid to studies on oral preeaneer. Oral Surg Oral Med Oral Pathol, 1978,46 ( 4 ) : 518- 539.
5Canrinci F, I.o Muzio L, Piattelli A, et al. Genetic portrait of mild and severe lingual dysplasia. Oral Oncol,2005,41 (4) : 365-374.
6Kelloff GJ, Sigman CC, Johnson KM, et al. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer. Cancer Epidemiol Biomarkers Prev, 2000,9 ( 2 ) : 127-137.
7Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, et al. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Chn Oncol, 2008,26(3) :354-360.
8Yuan P, Temam S, El-Naggar A, et al. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer,2006,107(3) :563-569.
9Atsumi N, Ishii G, Kojima M, et al. Podoplanin, a novel markerof tumor-initiating cells in human squamous cell carcinoma A431. Biochem Biophys Res Commun,2008 ,373(1):36-41.
10Kuribayashi Y, Morita K, Tomioka H, et al. Gene expression analysis by oligonucleotide microarray in oral leukoplakia. J Oral Pathol Med, 2009,38(4) :356-361.
